STAT6 specific shRNA inhibits proliferation and induces apoptosis in colon cancer HT-29 cells.

[1]  W. Koltun,et al.  Stat6(null phenotype) human lymphocytes exhibit increased apoptosis. , 2004, The Journal of surgical research.

[2]  Paavo Honkakoski,et al.  Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[3]  Phillip A. Sharp,et al.  The RNAi revolution , 2004, Nature.

[4]  Thomas Tuschl,et al.  siRNAs: applications in functional genomics and potential as therapeutics , 2004, Nature Reviews Drug Discovery.

[5]  W. Koltun,et al.  Human B lymphoblast cell lines defective of Stat6 signaling produce high levels of proinflammatory cytokines IL-12, TNFα and IFNγ , 2004 .

[6]  Jeong-Ho Kim,et al.  IGF-1 potentiation of IL-4-induced CD23/Fc(epsilon)RII expression in human B cells. , 2003, Molecules and cells.

[7]  F. Collins,et al.  A vision for the future of genomics research , 2003, Nature.

[8]  W. Koltun,et al.  Genetic control of interleukin-4-induced activation of the human signal transducer and activator of transcription 6 signaling pathway. , 2003, Human immunology.

[9]  R. Agami.  RNAi and related mechanisms and their potential use for therapy. , 2002, Current opinion in chemical biology.

[10]  Thomas Tuschl,et al.  Expanding small RNA interference , 2002, Nature Biotechnology.

[11]  E. Gelfand,et al.  Adoptive transfer of T cells induces airway hyperresponsiveness independently of airway eosinophilia but in a signal transducer and activator of transcription 6-dependent manner. , 2002, The Journal of allergy and clinical immunology.

[12]  Rajiv Dhir,et al.  Selective activation of members of the signal transducers and activators of transcription family in prostate carcinoma. , 2002, The Journal of urology.

[13]  R. Gascoyne,et al.  Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. , 2002, Blood.

[14]  M. Balter.  What--or Who--Did In the Neandertals? , 2001, Science.

[15]  M. Matzke,et al.  RNA: Guiding Gene Silencing , 2001, Science.

[16]  M. Grusby,et al.  Cutting Edge: STAT6-Deficient Mice Have Enhanced Tumor Immunity to Primary and Metastatic Mammary Carcinoma1 , 2000, The Journal of Immunology.

[17]  T. Rothstein,et al.  Inducible resistance to Fas-mediated apoptosis in B cells , 2000, Cell Research.

[18]  F. Fallarino,et al.  Spontaneous Rejection of Poorly Immunogenic P1.HTR Tumors by Stat6-Deficient Mice1 , 2000, The Journal of Immunology.

[19]  K. Deichmann,et al.  Atopy and asthma: genetic variants of IL-4 and IL-13 signalling , 2000 .

[20]  J. Schrader,et al.  IL-4 inhibits the production of TNF-alpha and IL-12 by STAT6-dependent and -independent mechanisms. , 1999, Journal of immunology.

[21]  M. Kaplan,et al.  Stat Proteins Control Lymphocyte Proliferation by Regulating p27Kip1 Expression , 1998, Molecular and Cellular Biology.

[22]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[23]  S. Akira,et al.  Impaired IL-13-mediated functions of macrophages in STAT6-deficient mice. , 1996, Journal of immunology.

[24]  S. Akira,et al.  Essential role of Stat6 in IL-4 signalling , 1996, Nature.

[25]  W. Paul,et al.  Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene , 1996, Nature.

[26]  M. Kaplan,et al.  Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. , 1996, Immunity.

[27]  I. Kerr,et al.  Jaks and Stats in signaling by the cytokine receptor superfamily. , 1995, Trends in genetics : TIG.

[28]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.

[29]  I. Roninson,et al.  Isolation of genetic suppressor elements, inducing resistance to topoisomerase II-interactive cytotoxic drugs, from human topoisomerase II cDNA. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Zhou Cong,et al.  Defective IL-4/Stat6 Signaling Correlates with Increased Apoptosis of Human EBV-lymphoblastoid B Cells and Mouse Spleen Cells , 2005 .

[31]  D. Yee,et al.  STAT6 mediates interleukin-4 growth inhibition in human breast cancer cells. , 2002, Neoplasia.

[32]  W. Paul,et al.  The IL-4 receptor: signaling mechanisms and biologic functions. , 1999, Annual review of immunology.

[33]  N. Copeland,et al.  Mouse Eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. , 1996, Immunity.

[34]  J. Darnell,et al.  Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.